Maze Therapeutics, Inc. (MAZE) › Cash & EquivalentsMaze Therapeutics, Inc. (MAZE) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $196.81M2025: $189.25M$189.25M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$189.25M-3.8%2024$196.81M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share